Coalition for Affordable Drugs IX, LLC et al. vs Bristol-Myers Squibb Company

The detailed information for PTAB case with proceeding number IPR2015-01723 filed by Coalition for Affordable Drugs IX, LLC et al. against Bristol-Myers Squibb Company on Aug 13, 2015. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.

Case Details

Proceeding Number: IPR2015-01723
Filing Date: Aug 13, 2015
Petitioner: Coalition for Affordable Drugs IX, LLC et al.
Respondent: Bristol-Myers Squibb Company
Status: Institution Denied
Respondent Application Number: 10245122
Respondent Tech Center: 1600
Respondent Patent Number: 6967208
Institution Decision Date: Feb 22, 2016
Termination Date: Feb 22, 2016

Proceeding Documents

The table below shows documents filed in the case, listing each document name, filing date, document type, and filing party. Tracking these filings indicates the activity of the parties involved in the case, and the types of documents filed can provide insights into the legal strategies being employed.

Show Exhibit Documents

Document Name	Filing Date	Category	Filing Party
Alert me when new update on this case
Decision Denying Institution	Feb 22, 2016	PAPER	BOARD
Petitioner's Updated Mandatory Notice	Jan 20, 2016	PAPER	PETITIONER
Patent Owner's Preliminary Response	Nov 24, 2015	PAPER	PATENT OWNER
Donald J.P. Pinto et al., Factor Xa Inhibitors- Next-Generation Antithrombotic Agents, 53 J. MED. CHEM. 6243, 6243 (2010)	Nov 24, 2015	EXHIBIT	PATENT OWNER
Pancras C. Wong et al., Apixaban, an Oral, Direct and Highly Selective Factor Xa Inhibitor- In Vitro, Antithrombotic and Antihemostatic Studies, 6 J. THROMBOSIS and HAEMOSTATIS 820 (2008)	Nov 24, 2015	EXHIBIT	PATENT OWNER
Donald J.P. Pinto et al., Case History- Eliquis (Apixaban), a Potent and Selective Inhibitor of Coagulation Factor Xa for the Prevention and Treatment of Thrombotic Diseases, 47 ANN. REP. MEDICINAL CHEMISTRY 123 (2012)	Nov 24, 2015	EXHIBIT	PATENT OWNER
Yun-Long Li et al., Preparation of 1-(3-aminobenzo-d-isoxazol-5-yl)-1H-pyrazolo-4,3-d-pyrimidin-7(6H)-ones as Potent, Selective, and Efficacious Inhibitors of Coagulation Factor Xa, 16 BIOORGANIC and MEDICINAL CHEMISTRY LETTERS 5176 (2006)	Nov 24, 2015	EXHIBIT	PATENT OWNER
Donald J.P. Pinto et al., Discovery of 1-(4-Methoxyphenyl)-7-oxo-6-(4-(2-oxopiperidin-1-yl)phenyl)-4,5,6,7-tetrahydro-1H-pyrazolo-3,4-c-pyridine-3-carboxamide (Apixaban, BMS-562247), a Highly Potent, Selective, Efficacious, and Orally Bioavailable Inhibito	Nov 24, 2015	EXHIBIT	PATENT OWNER
Press Release, American Chemical Society, -Heroes of Chemistry- Developed Products That Improve Health, Homes and Automobiles (June 29, 2015)	Nov 24, 2015	EXHIBIT	PATENT OWNER
Excerpts of File History for U.S. Patent No. 6,967,208	Nov 24, 2015	EXHIBIT	PATENT OWNER
Bengt I. Eriksson et al., Novel Oral Factor Xa and Thrombin Inhibitors in the Management of Thromboembolism, 62 ANN. REV. MED. 41 (2011)	Nov 24, 2015	EXHIBIT	PATENT OWNER
Bristol-Myers Squibb Co., Annual Report (Form 10-K) (Feb. 13, 2015)	Nov 24, 2015	EXHIBIT	PATENT OWNER
Bristol-Myers Squibb Co., Quarterly Report (Form 10-Q) (Oct. 27, 2015)	Nov 24, 2015	EXHIBIT	PATENT OWNER
Patent Owner Updated Mandatory Notice	Oct 22, 2015	PAPER	PATENT OWNER
Power of Attorney	Sep 2, 2015	PAPER	INDICATES ARTIFACT WAS SUBMITTED ON BEHALF OF POTENTIAL_PATENT OWNER.
Related Matters	Sep 2, 2015	PAPER	INDICATES ARTIFACT WAS SUBMITTED ON BEHALF OF POTENTIAL_PATENT OWNER.
Notice of Filing Data Accorded to Petition	Aug 27, 2015	PAPER	BOARD
Petition for IPR of 6,967,208	Aug 13, 2015	PAPER	PETITIONER
POA	Aug 13, 2015	PAPER	PETITIONER
Power of Attorney	Aug 13, 2015	PAPER	PETITIONER
U.S. 6,967,208	Aug 13, 2015	EXHIBIT	PETITIONER
Excerpts from File History of 6,967,208	Aug 13, 2015	EXHIBIT	PETITIONER
PCT Application WO 00/39131 (Fevig I)	Aug 13, 2015	EXHIBIT	PETITIONER
U.S. 6,413,980 (Fevig II)	Aug 13, 2015	EXHIBIT	PETITIONER
Excerpts from File History of 6,413,980	Aug 13, 2015	EXHIBIT	PETITIONER
PCT Application WO 95/01980	Aug 13, 2015	EXHIBIT	PETITIONER
Dec of George Burton	Aug 13, 2015	EXHIBIT	PETITIONER
Prescribing Information- Eliquis FDA Label	Aug 13, 2015	EXHIBIT	PETITIONER